You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Inhibition of methanogenesis

    SBC: BIONEBRASKA, INC.            Topic: N/A

    DESCRIPTION:(provided by applicant) The goal of this project is to develop a novel inhibitor of methane formation in ruminant animals. Currently, monensin, a relatively nonspecific antibiotic, is widely used in the livestock industry. Monensin increases agricultural productivity by decreasing methane and increasing propionate production; however, it also inhibits ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. CYTOTOXIC GONADOTROPIN RELEASING HORMONE DERIVATIVES

    SBC: GONEX, INC.            Topic: N/A

    Hormonally responsive cancers, such as prostate and breast, are a major cause of morbidity and mortality in the aging population in the United States. These cancers can be treated by sex steroid antagonists by these compounds are costly and mutational escape occurs. Recent innovative approaches have used hormonotoxins to specifically target the cancer cells. Several such approaches are already in ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. NOVEL BISPHOSPHONATES FOR BREAST CANCER THERAPY

    SBC: MBC Pharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Bisphosphonates are currently used as bone-specific palliative treatments for metastatic bone disease in multiple myeloma and breast cancer patients. However, bisphosphonate use has no proven impact on primary tumor burden and overall survival and only moderately reduces skeletal complications. Bisphosphonate conjugates were synthesized using proprietary techn ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. A novel vaccine/adjuvant for Streptococcus pneumoniae

    SBC: RxKinetix, Inc.            Topic: N/A

    N/A

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. OTOREFLECTANCE ASSESSMENT OF MIDDLE-EAR FUNCTIONING

    SBC: Sonicom, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Otoreflectance (OR) is a new class of hearing test instruments utilizing acoustic signals presented and recorded in the ear canal. OR instruments address limitations in existing screening and diagnostic instruments in such areas as: (1) detecting otitis media, (2) predicting conductive hearing loss, (3) augmenting the newborn hearing screening protocol to test ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  6. User adjustable support surfaces for wheelchair comfort

    SBC: FALCON REHABILITATION PRODUCTS            Topic: N/A

    DESCRIPTION (provided by applicant): Individuals with disabilities who require the use of wheelchairs for all of their independent mobility often experience problems with chronic seat discomfort in their wheelchairs. In spite of this prevalent problem, very little research has been done and few products have been specifically developed to mitigate chronic wheelchair seat discomfort. Chronic wheel ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Advanced Detection Technologies for Biochips

    SBC: INDEVR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of the proposed work is the development of innovative detection technologies for biochips (a.k.a. DNA microarrays). It is envisioned that the proposed technologies will enable the application of biochips to biodefense, particularly when a rapid and reliable diagnostic screen is required in the field. The Specific Aims of the proposed wo ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Nutrigram: Web-based Nutrition Education for Adolescents

    SBC: KLEIN BUENDEL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Recent reports indicate that adolescents are not following the Dietary Guidelines and are far from attaining the Healthy People 2010 nutrition goals. Most eat too much fat and sodium and inadequate amounts of fruits, vegetables, and calcium. They are snacking more, on less nutritional foods. In addition, there is an alarming increase in the prevalence of obesi ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Bisphosphonates for Multiple Myeloma Therapy

    SBC: MBC Pharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Bisphosphonates are currently used as bone-specific palliative treatments for the tumor-induced bone diseases observed in breast cancer and multiple myeloma patients. However, bisphosphonate use has no proven impact on primary tumor burden and overall survival and only moderately reduces skeletal complications. Bisphosphonate conjugates were synthesized using ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Prevention of osteoporosis with novel bisphosphonates

    SBC: MBC Pharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Bisphosphonates (BP) are a class of anti-resorptive drugs that target metabolic bone diseases characterized by accelerated states of skeletal turnover, such as post-menopausal osteoporosis. BPs have a high affinity for hydroxyapatite in bone matrix where it is released and incorporated by the osteoclast during bone resorption. Once intracellular, the BP disrupt ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government